Financhill
Back

Autolus Therapeutics PLC Vs. Biodexa Pharmaceuticals Plc Industry Stock Comparison

Sell
24

AUTL
Autolus Therapeutics PLC

Last Price:
3.48
Seasonality Move:
-14.93%
Sell
41

BDRX
Biodexa Pharmaceuticals Plc

Last Price:
0.89
Seasonality Move:
-1.3%
Sell
24
Autolus Therapeutics PLC (AUTL) is a Sell

Is Autolus Therapeutics PLC a Buy, Sell or Hold?

  • The current Autolus Therapeutics PLC [AUTL] share price is $3.49. The Score for AUTL is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • AUTL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Biodexa Pharmaceuticals Plc (BDRX) is a Sell

Is Biodexa Pharmaceuticals Plc a Buy, Sell or Hold?

  • The current Biodexa Pharmaceuticals Plc [BDRX] share price is $0.89. The Score for BDRX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • BDRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AUTL Stock Price Chart

What is Autolus Therapeutics PLC's stock price today?

  • The Autolus Therapeutics PLC share price today is $3.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUTL is experiencing buying pressure, which is a positive indicator for future bullish movement.

BDRX Stock Price Chart

What is Biodexa Pharmaceuticals Plc's stock price today?

  • The Biodexa Pharmaceuticals Plc share price today is $0.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing slight buying pressure.

AUTL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 38.55 Sell
Chaikin Money Flow: 487735 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.56 - 4.34) Sell
Bollinger Bands (100): (3.86 - 5.98) Sell

BDRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 44.39 Sell
Chaikin Money Flow: 22796 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.9 - 1.02) Sell
Bollinger Bands (100): (0.87 - 1.39) Sell

AUTL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.47 Buy
20-day SMA: 3.9 Sell
50-day SMA: 3.99 Sell
200-day SMA: 4.64 Sell
8-day EMA: 3.53 Sell
20-day EMA: 3.76 Sell
50-day EMA: 4.13 Sell
200-day EMA: 4.42 Sell

BDRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.88 Buy
20-day SMA: 0.95 Sell
50-day SMA: 1.06 Sell
200-day SMA: 2.17 Sell
8-day EMA: 0.9 Sell
20-day EMA: 0.95 Sell
50-day EMA: 1.04 Sell
200-day EMA: 27.76 Sell

Autolus Therapeutics PLC Earnings Growth & AUTL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.02 per share, an increase this year of $0.29 per share, and an increase next year of $0.16 per share.

Biodexa Pharmaceuticals Plc Earnings Growth & BDRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.

Autolus Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biodexa Pharmaceuticals Plc Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):